Price T Rowe Associates Inc Bio Techne Corp Transaction History

Price T Rowe Associates Inc

$935 Billion
Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,350,144 shares of TECH stock, worth $199 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,350,144

Previous 8,847,931 62.14%

Holding current value

$199 Million

Previous $455 Million 59.06%

% of portfolio

0.02%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$49.87 - $58.78 $274 Million - $323 Million	-5,497,787 Reduced 62.14%	3,350,144 $186 Million
Q2 2025 Aug 14, 2025	SELL	$46.66 - $58.38 $118 Million - $148 Million	-2,527,348 Reduced 22.22%	8,847,931 $455 Million
Q1 2025 May 14, 2025	BUY	$58.47 - $78.75 $42.2 Million - $56.8 Million	721,012 Added 6.77%	11,375,279 $667 Million
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $81.6 Million - $96.1 Million	1,229,954 Added 13.05%	10,654,267 $767 Million
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $63.8 Million - $74 Million	898,541 Added 10.54%	9,424,313 $753 Million

Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $173 Million - $234 Million	2,779,653 Added 48.37%	8,525,772 $611 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $182 Million - $212 Million	2,755,065 Added 92.11%	5,746,119 $404 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $45.8 Million - $67.8 Million	-866,612 Reduced 22.46%	2,991,054 $231 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $14.2 Million - $18.8 Million	-209,763 Reduced 5.16%	3,857,666 $263 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $263 Million - $306 Million	3,559,781 Added 701.23%	4,067,429 $332 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $40.2 Million - $48.7 Million	-561,663 Reduced 52.53%	507,648 $37.7 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $62.9 Million - $275 Million	779,246 Added 268.65%	1,069,311 $88.6 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $10.9 Million - $15.1 Million	38,563 Added 15.33%	290,065 $82.4 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $2.5 Million - $3.48 Million	-7,744 Reduced 2.99%	251,502 $87.2 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $3.75 Million - $5.16 Million	-10,586 Reduced 3.92%	259,246 $112 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $14.3 Million - $16.5 Million	31,364 Added 13.15%	269,832 $140 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $36.1 Million - $43.7 Million	81,156 Added 51.59%	238,468 $116 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $4.99 Million - $5.81 Million	-12,895 Reduced 7.58%	157,312 $70.8 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $2.7 Million - $3.52 Million	-8,570 Reduced 4.79%	170,207 $65 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $44.1 Million - $57.5 Million	178,777 New	178,777 $56.8 Million

Others Institutions Holding TECH

# of Institutions

648

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Bio Techne Corp Transaction History